Showing 1961-1970 of 4065 results for "".
Angiogenetic Therapies for Cancer Treatment
https://reachmd.com/programs/clinicians-roundtable/angiogenetic-therapies-for-cancer-treatment/3035/In 1971 Dr. Judah Folkman announced to the world that angiogenesis would be the Achilles heel of cancer-what's happened in the last 35 years? Dr. Walter M. Stadler, professor of medicine, director of Genitourinary Program, and associate dean of Clinical Research at the University of Chicago MedicalThe Future of Performance Enhancing Drugs and Testing
https://reachmd.com/programs/focus-on-sports-medicine/the-future-of-performance-enhancing-drugs-and-testing/3001/Looking beyond steroids in professional sports; what are the major drugs, how do they work, and who is using them? Looking at the red blood cell-boosting EPO, HGH, and the future of testing for performance enhancing drugs in sports is your host, Dr. Gary Kohn. Joining him is one of the world's premiTight Glycemic Control for the Critically Ill
https://reachmd.com/programs/focus-on-pharmacy/tight-glycemic-control-for-the-critically-ill/2771/When attempting to control blood sugar levels in critically ill patients, how far should we go? Host Dr. Charles Turck probes this question and more with Dr. Brian Smith, director of education in clinical services of the pharmacy department of the University of Massachussetts (UMass) Memorial MedicaThe Role of Presbyopia-Correcting Drops
https://reachmd.com/cme/ophthalmology/The-Role-of-Presbyopia-Correcting-Drops-2508/29737/Learn about miotics and how they work for presbyopia correction, especially for certain patients who are not ready for surgical options.Beyond Steroidal MRAs: The Nonsteroidal MRA Lens in HF
https://reachmd.com/programs/cme/beyond-steroidal-mras-the-nonsteroidal-mra-lens-in-hf/49198/Examine how nonsteroidal MRAs inform risk-based treatment in HFpEF and HFmrEF, including stable patients with ongoing cardio-kidney-metabolic risk.Groundbreaking AI Models Transform Cardiovascular Diagnosis
https://reachmd.com/programs/medical-industry-feature/groundbreaking-ai-models-transform-cardiovascular-diagnosis/29925/Discover how new AI models are leveraging cardiac imaging to detect structural heart disease earlier and expand access to life-saving screening.Hi-Lo Phaco: Settings and Details
https://reachmd.com/programs/cme/hi-lo-phaco-settings-and-details/33179/Learn how to fine-tune phaco settings in Venturi and peristaltic modes to enhance chamber stability and efficiency in cataract surgery.Breaking the Code: Mechanisms and Future Therapies for Refractory Chronic Cough
https://reachmd.com/programs/cme/breaking-the-code-mechanisms-and-future-therapies-for-refractory-chronic-cough/50974/Part of the educational program Bridging Specialties®: Timely Diagnosis and Treatment for Refractory Chronic Cough, this activity explores emerging scientific insights and therapeutic advances shaping the management of refractory chronic cough (RCC). Despite appropriate evaluation and treatment of cFrom Data to Debate: Global Perspectives on HR+/HER2- mBC Care
https://reachmd.com/programs/cme/from-data-to-debate-global-perspectives-on-hrher2-mbc-care/37268/Examine evolving global strategies for treating patients with HR+/HER2- mBC, integrating biomarker-driven therapy, clinical evidence, and toxicity management.Women in Aesthetics: Alesheia Randolph Bush, MBA
https://reachmd.com/ma-issues-index/2025-mar-apr/women-in-aesthetics-alesheia-randolph-bush-mba/36072/Get to know Alesheia Randolph Bush, MBA, VP-Global Professional + Industry Relations for ZO Skin Health, Inc.